妊娠合并先天性心脏病相关肺动脉高压孕妇的血流动力学及结局分析
前瞻性分析2015年1月至2017年12月北京安贞医院99例妊娠合并先天性心脏病相关肺动脉高压孕妇,按肺动脉收缩压分轻度、中度、重度及艾森曼格综合征组。各组妊娠期肺动脉收缩压均升高且终止妊娠后仍高于妊娠早期;重度及艾森曼格综合征组心功能Ⅲ~Ⅳ级比例更高、母儿不良结局更多。
要点
- 各组妊娠期肺动脉收缩压均升高,终止妊娠后虽下降但仍高于妊娠早期水平。
- 重度及艾森曼格综合征组心功能Ⅲ~Ⅳ级比例分别为61%(14/23)和12/17,高于轻度组8%(2/26)与中度组12%(4/33)。
- 重度及艾森曼格综合征组药物治疗比例及剖宫产率更高、终止妊娠孕周更早、新生儿出生体重更轻。
核心结论
- 妊娠合并先天性心脏病相关肺动脉高压孕妇妊娠期肺动脉收缩压均有不同程度增长,终止妊娠后虽下降但仍难以下降至妊娠早期水平,妊娠使原有心脏疾患加重。
- 妊娠合并重度肺动脉高压或艾森曼格综合征者右心房面积明显增大、左心室明显缩小、心功能Ⅲ~Ⅳ级比例更高,终止妊娠后2周内肺动脉收缩压与肱动脉收缩压比值仍持续上升,血流动力学波动大,母儿不良结局发生率高,属妊娠禁忌,应建议其避免妊娠。
研究设计与样本
- 前瞻性分析2015年1月至2017年12月首都医科大学附属北京安贞医院收治的妊娠合并先天性心脏病相关肺动脉高压孕妇共99例。
- 按妊娠期最高肺动脉收缩压分为轻度组(25~49 mmHg)26例、中度组(50~79 mmHg)33例、重度组(不合并艾森曼格综合征,≥80 mmHg)23例及艾森曼格综合征组17例。
主要发现
- 四组孕妇妊娠期肺动脉收缩压均有不同程度增长,增长值及增长率组间比较差异均无统计学意义(P>0.05);终止妊娠后各组均有所下降,但仍分别高于其妊娠早期水平。
- 中度组右心房面积增大值为2 cm²(1~5 cm²)、重度组为5 cm²(3~9 cm²)、艾森曼格综合征组为5 cm²(3~6 cm²),分别与轻度组1 cm²(-1~4 cm²)比较差异均有统计学意义(P均<0.05)。
- 中度组左心室舒张末期内径变化为1.0 cm(-2.0~2.0 cm)、重度组为-3.5 cm(-6.0~1.0 cm)、艾森曼格综合征组为-1.0 cm(-5.5~2.0 cm),分别与轻度组3.0 cm(1.0~6.0 cm)比较差异均有统计学意义(P均<0.05)。
- 四组妊娠期肺动脉收缩压与肱动脉收缩压比值均持续上升,终止妊娠后2周内轻、中度组有所下降,重度组及艾森曼格综合征组仍持续上升。
- 重度组、艾森曼格综合征组心功能Ⅲ~Ⅳ级者比例分别为61%(14/23)、12/17,分别与轻度组8%(2/26)、中度组12%(4/33)两两比较差异均有统计学意义(P<0.05)。
临床怎么用
- 作者认为,妊娠合并重度先天性心脏病相关肺动脉高压或艾森曼格综合征者属妊娠禁忌,应建议其避免妊娠。
- 作者认为,妊娠会使先天性心脏病相关肺动脉高压孕妇原有心脏疾患加重,妊娠前及妊娠期应充分考虑风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To observe and analysis the changes of hemodynamic parameters and outcomes of pregnant women combined with congenital heart disease-pulmonary arterial hypertension (CHD-PAH). Methods: A prospective analysis of hemodynamic parameters of patients combined with CHD-PAH in Beijing Anzhen Hospital from January 2015 to December 2017 was carried out. Total 99 cases were divided into 4 groups based on systolic pulmonary arterial pressure (SPAP): mild group (SPAP 25-49 mmHg, 1 mmHg=0.133 kPa), moderate group (SPAP 50-79 mmHg), severe group (SPAP≥80 mmHg) and Eisenmenger syndrome group. Results: (1) SPAP of all groups increased during gestation, and the growth rates had no statistical differences (P>0.05). The SPAP in each group decreased after termination but was still higher than the early pregnancy's SPAP. (2) CHD-PAH patients in moderate [2 cm(2) (1-5 cm(2)), 1.0 cm (-2.0 - 2.0 cm)], severe [5 cm(2) (3-9 cm(2)), -3.5 cm (-6.0 - 1.0 cm)] or Eisenmenger syndrome [5 cm(2) (3-6 cm(2)), -1.0 cm (-5.5 - 2.0 cm)] group had larger right atrium area and smaller left ventricular end-diastolic diameter than patients in mild group [1 cm(2) (-1 - 4 cm(2)), 3.0 cm (1.0-6.0 cm)], the differences were statistically significant (all P<0.05). (3) Each group's SPAP/brachial arterial-systolic (BSAP) pressure continously increased during gestation. The SPAP/BSAP only decreased in patients in mild or moderate group after termination. However, the SPAP/BSAP kept rising in patients in severe group or Eisenmenger syndrome group. (4) CHD-PAH patients in severe or Eisenmenger syndrome group had worse cardiac function, in which the rates of Ⅲ-Ⅳ cardiac function were 61%(14/23) and 12/17, compared with patients in mild [8% (2/26)] and moderate [12%(4/33)] group, the differences were statistically significant (all P<0.05). (5) The rates of medicine treatment, cesarean section were higher, the weeks of gestational termination were earlier and the newborn's weights were lower in patients in severe or Eisenmenger syndrome group, the differences were statistically significant (all P<0.05). Conclusions: (1) SPAP keeps rising during gestation in all patients with CHD-PAH, and the SPAP decreases after termination but it's still higher than the early pregnancy's SPAP. This suggests that pregnancy would exacerbate these patients' heart problems, the risk should be fully considered before and during pregnancy. (2) Patients with severe CHD-PAH or combined with Eisenmenger syndrome have lager right atrium area, smaller left ventricular end-diastolic diameter, worse cardiac function, and bigger changes of hemodynamic, the incidence of adverse outcomes of mothers and children is also high, pregnancy should be avoided. 目的: 探讨妊娠合并先天性心脏病相关的肺动脉高压(CHD-PAH)孕妇妊娠期及分娩后重要血流动力学参数的变化趋势。 方法: 收集2015年1月至2017年12月首都医科大学附属北京安贞医院收治的妊娠合并CHD-PAH孕妇共99例,根据其妊娠期最高肺动脉收缩压(SPAP)分为:轻度组(SPAP为25~49 mmHg;1 mmHg=0.133 kPa)26例、中度组(SPAP为50~79 mmHg)33例、重度组(不合并艾森曼格综合征,SPAP≥80 mmHg)23例,及艾森曼格综合征组17例,观察其妊娠期及分娩后的血流动力学参数和血流动力学变化趋势,并分析其妊娠结局。 结果: (1)轻、中、重度组及艾森曼格综合征组孕妇妊娠期的SPAP均有不同程度的增长,4组孕妇SPAP的增长值比较,差异无统计学意义(P>0.05);4组孕妇SPAP的增长率比较,差异无统计学意义(P>0.05)。终止妊娠后各组孕妇的SPAP均有所下降,但仍分别高于其妊娠早期的SPAP水平。(2)中度组孕妇妊娠期右心房面积的增大值为2 cm(2)(1~5 cm(2)),重度组为5 cm(2)(3~9 cm(2)),艾森曼格综合征组为5 cm(2)(3~6 cm(2)),分别与轻度组1 cm(2)(-1~4 cm(2))比较,均有明显差异(P均<0.05)。中度组孕妇的妊娠期左心室舒张末期内径变化为1.0 cm(-2.0~2.0 cm),重度组为-3.5 cm(-6.0~1.0 cm),艾森曼格综合征组为-1.0 cm(-5.5~2.0 cm),分别与轻度组3.0 cm(1.0~6.0 cm)比较,均有明显差异(P均<0.05)。(3)4组妊娠合并CHD-PAH孕妇的妊娠期SPAP/肱动脉收缩压(BSAP)均持续上升,终止妊娠后2周内轻、中度组孕妇的SPAP/BSAP有所下降,重度组及艾森曼格综合征组孕妇的SPAP/BSAP仍持续上升。(4)重度组、艾森曼格综合征组孕妇中心功能Ⅲ~Ⅳ级者的比例分别为61%(14/23)、12/17,分别与轻、中度组[8%(2/26),12%(4/33)]两两比较有明显差异,差异均有统计学意义(P<0.05)。(5)重度组及艾森曼格综合征组孕妇较轻、中度组孕妇的使用药物治疗者的比例及剖宫产率更高、终止妊娠孕周更早、新生儿的出生体重更轻,分别比较,差异均有统计学意义(P均<0.05)。 结论: (1)妊娠合并CHD-PAH孕妇的妊娠期SPAP均有不同程度的增长,终止妊娠后SPAP虽有所下降,但难以下降到妊娠早期的SPAP水平;妊娠使孕妇原有的心脏疾患加重。(2)妊娠合并重度CHD-PAH、艾森曼格综合征孕妇的妊娠期右心房面积明显增大,左心室明显缩小,妊娠晚期心功能Ⅲ~Ⅳ级者的比例更高,且终止妊娠后2周内SPAP/BSAP仍持续上升,血流动力学波动大,病情危重,母儿不良结局的发生率高,属妊娠禁忌,应建议其避免妊娠。.
引用
- Zhang LL, Zhang J. [Analysis of hemodynamics and outcomes of pregnant women with congenital heart disease-pulmonary arterial hypertension]. Zhonghua Fu Chan Ke Za Zhi. 2019. PMID: 31365955. doi:10.3760/cma.j.issn.0529-567x.2019.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。